Cocaine remains a major public health concern due to a continuing increase in the number of emergency room admissions following cocaine use. Cardiovascular complications represent a large proportion of these admissions. Cardiovascular effects of cocaine are being extensively studied using various species of animals as model systems. Recent research has focused on the influence of conditioning on the cardiovascular effects of cocaine. Most human drug abusers consistently use cocaine in the same environment. It is possible that the cardiovascular effects of cocaine could become conditioned to that environment to either augment or counteract those effects. In squirrel monkeys, cocaine injections were consistently paired with a tone-light conditioned stimulus. By the third stimulus-cocaine pairing, a conditioned response was observed that was drug-like. That is, the conditioned response to the tone-light stimulus was similar to the unconditioned effect of cocaine in that both heart rate and blood pressure were increased. This effect may serve to augment the cardiovascular effects of cocaine. The conditioned response was also long lasting. After 10 conditioning trials, the cocaine injections were stopped (extinction). In one monkey, a response to the conditioned stimulus that was above baseline levels was still observed after 30 extinction trials. These results suggest that the conditioned cardiovascular effects of cocaine may well contribute to some of the adverse effects seen following cocaine administration. In other studies, cardiovascular responses to chronic limited access (2 hr/day) cocaine self-administration were studied in Sprague-Dawley rats implanted with telemetric devices. Following training to lever press for food, rats were tested for cocaine (1 mg/kg/infusion) self- administration for four weeks, followed by extinction with saline during week 5, and then re-testing of cocaine self-administration during week 6. The first infusion of cocaine within a given session produced rapid (less then 60 sec) increases in diastolic, systolic and mean pressures and in heart rate (HR). The subsequent cocaine infusions within the same session produced increases in pressures that were significantly smaller than that of the first infusion and failed to increase HR. These patterns of responses were seen on all days of testing, however, the mean increases in pressures and HR produced by the first infusions during the daily sessions of weeks 4 and 6 were significantly smaller as compared to the corresponding increases seen during the first week of testing. These data indicate that there are two kinds of tolerance to pressor and tachycardiac responses to cocaine. One is an acute tolerance, which occurs within each session following a single infusion of cocaine, while the other is a chronic tolerance which occurs over several weeks of cocaine self- administration.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000009-13
Application #
6103851
Study Section
Special Emphasis Panel (BNRB)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Schindler, Charles W; Graczyk, Zofi; Gilman, Joanne P et al. (2007) Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys. Eur J Pharmacol 576:107-13
Schindler, Charles W; Karcz-Kubicha, Marzena; Thorndike, Eric B et al. (2005) Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 144:642-50
Schindler, Charles W; Karcz-Kubicha, Marzena; Thorndike, Eric B et al. (2004) Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680. Eur J Pharmacol 484:269-75
Schindler, Charles W; Gilman, Joanne P; Graczyk, Zofi et al. (2003) Reduced cardiovascular effects of methamphetamine following treatment with selegiline. Drug Alcohol Depend 72:133-9
Schindler, C W; Gilman, J P; Bergman, J et al. (2002) Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys. J Pharmacol Exp Ther 300:180-7
Schindler, C W; Zheng, J W; Goldberg, S R (2001) Effects of cocaine and cocaine metabolites on cardiovascular function in squirrel monkeys. Eur J Pharmacol 431:53-9
Tella, S R; Schindler, C W; Goldberg, S R (1999) Cardiovascular responses to cocaine self-administration: acute and chronic tolerance. Eur J Pharmacol 383:57-68
Erzouki, H K; Goldberg, S R; Schindler, C W (1999) Comparison of cocaine and Na+ channel blockers on cardio-respiratory function in the rabbit. Eur J Pharmacol 377:51-6
Itokawa, K; Sora, I; Schindler, C W et al. (1999) Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden death. Brain Res Mol Brain Res 71:354-7